An investigation has revealed that Israel is using US-made Taser weapons supplied by Axon on Palestinian detainees, with human rights groups including Amnesty International condemning the alleged repeated torture and ill-treatment. An Axon spokesperson did not address the allegations, while an Israel Defense Forces spokesperson said abuse of detainees is strictly prohibited. Amnesty has called for restrictions on exports of such devices.
Why it matters
The continued supply of electroshock weapons by a US company to Israeli forces despite documented allegations of torture raises questions about US arms export oversight and compliance with international humanitarian standards.
What remains uncertain
The extent and frequency of alleged torture using these devices, and whether Axon was aware of the allegations before continuing supply, remain unconfirmed.
The chart totals every SEC-reported transaction by month and share count, separating informative purchases and sales from non-informative awards, vesting, exercises, tax withholding and transfers. Records without a reported price remain included. Only informative purchases and sales affect the conservative sentiment signal.
Recent SEC-reported share and derivative transactions in AXON ENTERPRISE, INC..
As filed with the SEC. Estimated value is shown only for purchases or sales with a positive reported transaction price; awards, gifts and similar activity are not assigned an assumed market value. Amendments may change the record. This is not investment advice.
Quarterly reported positions. These filings can arrive up to 45 days after quarter-end and are not real-time trades.
Institutional ownership: 100.50%
Short interest
Open short positions reported twice monthly; this is not daily short-sale volume.
Earnings
Recent reported earnings per share compared with the analyst consensus available from Nasdaq.
